Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.9400
-0.0440 (-4.47%)
Oct 6, 2025, 4:00 PM EDT - Market closed
Cytosorbents Revenue
Cytosorbents had revenue of $9.62M in the quarter ending June 30, 2025, with 8.76% growth. This brings the company's revenue in the last twelve months to $36.11M, up 20.18% year-over-year. In the year 2024, Cytosorbents had annual revenue of $35.59M with 14.51% growth.
Revenue (ttm)
$36.11M
Revenue Growth
+20.18%
P/S Ratio
1.58
Revenue / Employee
$242,332
Employees
149
Market Cap
59.00M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 35.59M | 4.51M | 14.51% |
Dec 31, 2023 | 31.08M | -3.60M | -10.39% |
Dec 31, 2022 | 34.69M | -8.48M | -19.64% |
Dec 31, 2021 | 43.17M | 2.16M | 5.27% |
Dec 31, 2020 | 41.00M | 16.06M | 64.35% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
CTSO News
- 7 days ago - CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen - PRNewsWire
- 20 days ago - CytoSorbents Provides DrugSorb-ATR Regulatory Update - PRNewsWire
- 4 weeks ago - CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day - PRNewsWire
- 4 weeks ago - CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference - PRNewsWire
- 6 weeks ago - CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR - PRNewsWire
- 2 months ago - Cytosorbents Corporation (CTSO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update - PRNewsWire
- 2 months ago - CytoSorbents Leads a New Era in Sepsis Treatment - PRNewsWire